Fritextsökning
Innehållstyper
-
Changeable proteins cause nerve disease
An incorrectly folded protein is one of the reasons behind the nerve disease ALS, according to new research. But the protein does not have structural errors all...
-
USB recycler for liquid chromatography
The Smartsaver recycler from Biotech AB is designed to recycle the uncontaminated mobile phase in isocratic liquid chromatography.
-
EU grants project on toxicity of nanomaterials
A multinational research project has have been awarded EUR 3 358 500 from the European Commission to study the hazardous effects of engineered nanomaterials on ...
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
Infidelity produces faster sperms
Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.
-
Microwave reactor for use in various synthesis applications
The Monowave 300 microwave reactor offers 850 watts of power for a variety of synthesis applications.
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Norwegian entrance in EU technology network
The Norwegian University of Science and Technology joins the European Science Business Network of prominent European research institutions.
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Danish discovery could help cardiac patients
The Danish researchers have developed a component that could make live easier forpatients with heart failure.
-
Danisco strengthens its IP team
Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.
-
SDU professor helps EU
Mette Præst Knudsen from the University of Southern Denmark, SDU, has been appointed as an expert member in an EU politics group.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Danish biorefinery can save US billions
The Danish Inbicon biorefinery process could save the US billions on foreign oil, the organization states.
-
Rosling-kurs på KI för alla
Nu finns en online-kurs i global hälsa baserad på Hans Roslings kunskaper och metoder. Kursen vid KI är öppen för alla.
-
Astra Zenecas flytt till Hagastaden: ”Äntligen är vi här"
Samarbete mellan life science-bolag, akademin och hälso- och sjukvården var ledord när Astra Zenecas nordiska huvudkontor invigdes i Hagastaden under måndagen.
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
Fewer visitors but satisfied exhibitors
Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.
-
Biogaia's advance goes on
In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.
-
Hon tar plats på Bactiguard
Petra Kaur Ljungman tillträder den nyinrättade rollen som global marknads- och kommunikationschef.
-
Legionellafall efter hantering av trädgårdsjord
Ovanligt många har insjuknat i legionellainfektion i Sverige. Gemensamt för de flesta som insjuknat är att de har hanterat trädgårdsjord och jord köpt i påse.
-
Irene Svenonius: ”Vi har urstarka förutsättningar att förverkliga målet inom life science"
Finansregionrådet Irene Svenonius (M) tror att Stockholm kan nå målet att höra till världens topp 5 regioner inom life science till år 2025. Och en del i att nå...